Infection with Fasciola hepatica
Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosi...
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2005-11, Vol.11 (11), p.859-861 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 861 |
|---|---|
| container_issue | 11 |
| container_start_page | 859 |
| container_title | Clinical microbiology and infection |
| container_volume | 11 |
| creator | Aksoy, D.Y. Kerimoglu, U. Oto, A. Erguven, S. Arslan, S. Unal, S. Batman, F. Bayraktar, Y. |
| description | Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative. |
| doi_str_mv | 10.1111/j.1469-0691.2005.01254.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68683867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14625982</els_id><sourcerecordid>68683867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4764-c3d8345d594fdde6b85d7c32719442e156120b289227603d20ba3b25fad0c7633</originalsourceid><addsrcrecordid>eNqNkE1PwzAMhiMEYmPwF1BP3Fry1TQ9cICJAdIQF5C4RWniapm6djQd2_49KZ3gCL7Ylt_Xth6EIoITEuJ6mRAu8hiLnCQU4zTBhKY82R2h8c_gONQkl3HG2fsInXm_xBhTxvgpGhFBicC5HKPoqS7BdK6po63rFtFMe-OaSkcLWOvOGX2OTkpdebg45Al6m92_Th_j-cvD0_R2HhueCR4bZiXjqU1zXloLopCpzQyjGck5p0BSQSguqMwpzQRmNjSaFTQttcUmE4xN0NWwd902HxvwnVo5b6CqdA3NxishhWRSZEEoB6FpG-9bKNW6dSvd7hXBqqejlqqHoHoIqqejvumoXbBeHm5sihXYX-MBRxDcDIKtq2D_78VqOn_uq-C_G_wQSH06aFWgCbUB69pAWdnG_f3lF0UFhbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68683867</pqid></control><display><type>article</type><title>Infection with Fasciola hepatica</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Aksoy, D.Y. ; Kerimoglu, U. ; Oto, A. ; Erguven, S. ; Arslan, S. ; Unal, S. ; Batman, F. ; Bayraktar, Y.</creator><creatorcontrib>Aksoy, D.Y. ; Kerimoglu, U. ; Oto, A. ; Erguven, S. ; Arslan, S. ; Unal, S. ; Batman, F. ; Bayraktar, Y.</creatorcontrib><description>Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2005.01254.x</identifier><identifier>PMID: 16216098</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Animals ; Antiplatyhelmintic Agents - pharmacology ; Antiplatyhelmintic Agents - therapeutic use ; Benzimidazoles - pharmacology ; Benzimidazoles - therapeutic use ; Biopsy ; Bithionol - pharmacology ; Bithionol - therapeutic use ; Cholangiography ; Diagnosis ; Enzyme-Linked Immunosorbent Assay ; Fasciola hepatica ; Fasciola hepatica - drug effects ; fascioliasis ; Fascioliasis - diagnosis ; Fascioliasis - drug therapy ; Fascioliasis - pathology ; Fascioliasis - physiopathology ; Feces - parasitology ; Humans ; liver fluke ; Magnetic Resonance Imaging ; Tomography, X-Ray Computed ; treatment ; Ultrasonography</subject><ispartof>Clinical microbiology and infection, 2005-11, Vol.11 (11), p.859-861</ispartof><rights>2005 European Society of Clinical Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4764-c3d8345d594fdde6b85d7c32719442e156120b289227603d20ba3b25fad0c7633</citedby><cites>FETCH-LOGICAL-c4764-c3d8345d594fdde6b85d7c32719442e156120b289227603d20ba3b25fad0c7633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2005.01254.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2005.01254.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16216098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aksoy, D.Y.</creatorcontrib><creatorcontrib>Kerimoglu, U.</creatorcontrib><creatorcontrib>Oto, A.</creatorcontrib><creatorcontrib>Erguven, S.</creatorcontrib><creatorcontrib>Arslan, S.</creatorcontrib><creatorcontrib>Unal, S.</creatorcontrib><creatorcontrib>Batman, F.</creatorcontrib><creatorcontrib>Bayraktar, Y.</creatorcontrib><title>Infection with Fasciola hepatica</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative.</description><subject>Animals</subject><subject>Antiplatyhelmintic Agents - pharmacology</subject><subject>Antiplatyhelmintic Agents - therapeutic use</subject><subject>Benzimidazoles - pharmacology</subject><subject>Benzimidazoles - therapeutic use</subject><subject>Biopsy</subject><subject>Bithionol - pharmacology</subject><subject>Bithionol - therapeutic use</subject><subject>Cholangiography</subject><subject>Diagnosis</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fasciola hepatica</subject><subject>Fasciola hepatica - drug effects</subject><subject>fascioliasis</subject><subject>Fascioliasis - diagnosis</subject><subject>Fascioliasis - drug therapy</subject><subject>Fascioliasis - pathology</subject><subject>Fascioliasis - physiopathology</subject><subject>Feces - parasitology</subject><subject>Humans</subject><subject>liver fluke</subject><subject>Magnetic Resonance Imaging</subject><subject>Tomography, X-Ray Computed</subject><subject>treatment</subject><subject>Ultrasonography</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1PwzAMhiMEYmPwF1BP3Fry1TQ9cICJAdIQF5C4RWniapm6djQd2_49KZ3gCL7Ylt_Xth6EIoITEuJ6mRAu8hiLnCQU4zTBhKY82R2h8c_gONQkl3HG2fsInXm_xBhTxvgpGhFBicC5HKPoqS7BdK6po63rFtFMe-OaSkcLWOvOGX2OTkpdebg45Al6m92_Th_j-cvD0_R2HhueCR4bZiXjqU1zXloLopCpzQyjGck5p0BSQSguqMwpzQRmNjSaFTQttcUmE4xN0NWwd902HxvwnVo5b6CqdA3NxishhWRSZEEoB6FpG-9bKNW6dSvd7hXBqqejlqqHoHoIqqejvumoXbBeHm5sihXYX-MBRxDcDIKtq2D_78VqOn_uq-C_G_wQSH06aFWgCbUB69pAWdnG_f3lF0UFhbg</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>Aksoy, D.Y.</creator><creator>Kerimoglu, U.</creator><creator>Oto, A.</creator><creator>Erguven, S.</creator><creator>Arslan, S.</creator><creator>Unal, S.</creator><creator>Batman, F.</creator><creator>Bayraktar, Y.</creator><general>Elsevier Ltd</general><general>Blackwell Science Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200511</creationdate><title>Infection with Fasciola hepatica</title><author>Aksoy, D.Y. ; Kerimoglu, U. ; Oto, A. ; Erguven, S. ; Arslan, S. ; Unal, S. ; Batman, F. ; Bayraktar, Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4764-c3d8345d594fdde6b85d7c32719442e156120b289227603d20ba3b25fad0c7633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antiplatyhelmintic Agents - pharmacology</topic><topic>Antiplatyhelmintic Agents - therapeutic use</topic><topic>Benzimidazoles - pharmacology</topic><topic>Benzimidazoles - therapeutic use</topic><topic>Biopsy</topic><topic>Bithionol - pharmacology</topic><topic>Bithionol - therapeutic use</topic><topic>Cholangiography</topic><topic>Diagnosis</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fasciola hepatica</topic><topic>Fasciola hepatica - drug effects</topic><topic>fascioliasis</topic><topic>Fascioliasis - diagnosis</topic><topic>Fascioliasis - drug therapy</topic><topic>Fascioliasis - pathology</topic><topic>Fascioliasis - physiopathology</topic><topic>Feces - parasitology</topic><topic>Humans</topic><topic>liver fluke</topic><topic>Magnetic Resonance Imaging</topic><topic>Tomography, X-Ray Computed</topic><topic>treatment</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aksoy, D.Y.</creatorcontrib><creatorcontrib>Kerimoglu, U.</creatorcontrib><creatorcontrib>Oto, A.</creatorcontrib><creatorcontrib>Erguven, S.</creatorcontrib><creatorcontrib>Arslan, S.</creatorcontrib><creatorcontrib>Unal, S.</creatorcontrib><creatorcontrib>Batman, F.</creatorcontrib><creatorcontrib>Bayraktar, Y.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aksoy, D.Y.</au><au>Kerimoglu, U.</au><au>Oto, A.</au><au>Erguven, S.</au><au>Arslan, S.</au><au>Unal, S.</au><au>Batman, F.</au><au>Bayraktar, Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infection with Fasciola hepatica</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2005-11</date><risdate>2005</risdate><volume>11</volume><issue>11</issue><spage>859</spage><epage>861</epage><pages>859-861</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>16216098</pmid><doi>10.1111/j.1469-0691.2005.01254.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2005-11, Vol.11 (11), p.859-861 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68683867 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Animals Antiplatyhelmintic Agents - pharmacology Antiplatyhelmintic Agents - therapeutic use Benzimidazoles - pharmacology Benzimidazoles - therapeutic use Biopsy Bithionol - pharmacology Bithionol - therapeutic use Cholangiography Diagnosis Enzyme-Linked Immunosorbent Assay Fasciola hepatica Fasciola hepatica - drug effects fascioliasis Fascioliasis - diagnosis Fascioliasis - drug therapy Fascioliasis - pathology Fascioliasis - physiopathology Feces - parasitology Humans liver fluke Magnetic Resonance Imaging Tomography, X-Ray Computed treatment Ultrasonography |
| title | Infection with Fasciola hepatica |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A53%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infection%20with%20Fasciola%20hepatica&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Aksoy,%20D.Y.&rft.date=2005-11&rft.volume=11&rft.issue=11&rft.spage=859&rft.epage=861&rft.pages=859-861&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2005.01254.x&rft_dat=%3Cproquest_cross%3E68683867%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68683867&rft_id=info:pmid/16216098&rft_els_id=S1198743X14625982&rfr_iscdi=true |